Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • J

    - PMLiVE

    Roche and Oxford BioTherapeutics enter oncology partnership worth over $1bn

    The companies will aim to discover new antibody-based therapeutics for cancer

    - PMLiVE

    Innovative Trials Announces New Charity Partnerships

    Innovative Trials, a global patient recruitment and retention company, has just announced GOSH Charity and Oliver Patch Project as their charity partners of the year

    Innovative Trials

    - PMLiVE

    Eli Lilly and Radionetics Oncology enter $140m radiopharma partnership

    The strategic agreement also gives Lilly the exclusive right to acquire the biotech for $1bn

    tijana being interviewed

    Envision Analogue – An Introduction

    Powered by primary payer market research, Envision is an online platform that provides forward-looking evaluations and comprehensive strategic direction for market access viability after an oncology product has received positive...

    Genesis Research Group

    - PMLiVE

    Ipsen enters $900m licensing agreement for Sutro Biopharma’s ADC candidate

    STRO-003 will be the first ADC candidate to be added to Ipsen’s portfolio

    - PMLiVE

    New technique enables study of immune response to cancer using archived tissue samples

    FUME-TCRseq was shown to successfully read formalin-fixed paraffin-embedded tissue samples

    - PMLiVE

    Gilead and Merus announce oncology partnership worth over $1.5bn

    The companies will aim to discover dual tumour-associated antigens targeting trispecific antibodies

    - PMLiVE

    Researchers develop screening tool to investigate mechanisms behind multiple diseases

    The technique will assess genetic changes in cells behind cancer, autoimmunity and neurodegeneration

    - PMLiVE

    ‘Click chemistry’ system used to map new class of drug targets in cancer and immunology

    The novel tagging system won the Nobel Prize in Chemistry in October 2022

    - PMLiVE

    Gilead gains rights to Compugen’s immunotherapy programme in deal worth $848m

    The high affinity antibody blocks the interaction between IL-18 binding protein and IL-18

    - PMLiVE

    Merck and Owkin collaborate to develop AI-powered diagnostics for cancer

    The companies aim to develop a pre-screening test to improve MSI-H testing for cancer

    - PMLiVE

    Cancer Research UK calls on government to create ten-year cancer plan

    The charity estimates that around 20,000 annual cancer deaths in the UK could be prevented by 2040

    Subscribe to our email news alerts

    Latest content

    Latest intelligence

    Quick links